Total Antibody Detection ELISA 

SARS-CoV-2 Clinical Diagnostic Kits – Quick and Effective

Diagnosis

While molecular diagnostic techniques are a direct indicator of disease, serological techniques are an indirect diagnostic assay, which determines whether a person has overcome the disease and is therefore immunized. Thus, it is a complementary technique to PCR, especially in those cases where PCR gives a negative result.

Status determination

The presence of specific antibodies to SARS-CoV-2 in patient samples indirectly proves that the individual has suffered from the infection.

The GSD INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. The N protein is one of the most abundant early-onset proteins of the virus, as well as being highly immunogenic and therefore a good candidate antigen for the diagnosis of COVID19.

Total Antibody Detection ELISA Immunoassays

GSD INgezim COVID 19 DR

  • Double recognition ELISA for the determination of total antibodies in serum samples. Capable of detecting all isotypes (IgG, IgM, and IgA) in a single sample
  • Total incubation: 1 hour and 15 minutes
  • No sample pre-dilution required
  • Compatible with various open platform ELISA analyzers

Art. No.

GSD.R.50.CoV.K0

 

Product

GSD INgezym COVID 19 DR

 

Number of Tests

96

 

Description

Double recognition ELISA for the determination of total antibodies in serum samples.